Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC)

Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
12. 03
-0.32
-2.5911%
After Hours
$
13. 83
+1.8 +14.9626%
426.22M Market Cap
- P/E Ratio
- Div Yield
348,050 Volume
0.23 Eps
$ 12.35
Previous Close
Add Transaction
Day Range
11.93 12.37
Year Range
5.65 13.25
Want to track FENC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Fennec Pharmaceuticals Inc. (FENC) Statistics

Valuation metrics

Market Cap 426.22M
Enterprise value 384.97M
Trailing P/E (ttm) -94.38
Forward P/E -
PEG ratio -1.68
Price/Sales (ttm) 7.2
Price/Book (mrq) 9.99
Enterprise Value/Revenue 6.5
Enterprise Value/EBITDA -162.03

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 421.65K
Average volume (90 days) 196.39K

Price summary

52-Week low 5.65
52-Week high 13.25
Beta -
50-Day moving average 10.39
200-Day moving average 7.79

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 5 Sep 2014

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.05%
Operating margin -0.02%

Operational effectiveness

Return on assets -0.04%
Return on equity -0.12%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.71
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.09
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.19
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 5.85%
Book value per share (mrq) 1.23

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -